Cordycepin inhibits renal interstitial myofibroblast activation probably by inducing hepatocyte growth factor expression

Journal of Pharmacological Sciences

Volumn 117, Issue 4, 2011, Pages 286-294

  Li, Li ^a,b   He, Dongyuan ^a,c   Yang, Junwei ^a   Wang, Xiaoyun ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Medical College of Southeast University   (China)

^c ZHEJIANG HOSPITAL   (China)

Author keywords

Cordycepin; Hepatocyte growth factor; Myofibroblast; Renal fibrosis; Transforming growth factor 1

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CORDYCEPIN; FIBRONECTIN; MESSENGER RNA; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; SMAD PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; IMMUNOFLUORESCENCE; KIDNEY CELL; MYOFIBROBLAST; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; RAT; WESTERN BLOTTING;

EID: 84862931981     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.11127FP     Document Type: Article

References (30)

1. Liu Y. Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int. 2006;69:213-217. (Pubitemid 43323069)
2. Eddy AA. Progression in chronic kidney disease. Adv Chronic Kidney Dis. 2005;12:353-365. (Pubitemid 41376493)
3. Strutz F, Zeisberg M. Renal fibroblasts and myofibroblasts in chronic kidney disease. J Am Soc Nephrol. 2006;17:2992-2998. (Pubitemid 44707759)
4. Bottinger EP, Bitzer M. TGF-beta1 signaling in renal disease. J Am Soc Nephrol. 2002;13:2600-2610.
5. Harris RC, Neilson EG. Toward a unified theory of renal progression. Annu Rev Med. 2006;57:365-380. (Pubitemid 43261996)
6. Matsumoto K, Nakamura T. Emerging multipotent aspects of hepatocyte growth factor. J Biochem. 1996;119:591-600. (Pubitemid 26131762)
7. Bottaro DP, Rubin JS, Faletto DL, Chan AM, Kmiecik TE, Vande Woude GF, et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science. 1991; 251:802-804. (Pubitemid 21926175)
8. Liu Y. Hepatocyte growth factor promotes renal epithelial cell survival by dual mechanisms. Am J Physiol Renal Physiol. 1999;277:624-633.
9. Yang J, Dai C, Liu Y. Hepatocyte growth factor suppresses renal interstitial myofibroblast activation and intercepts Smad signal transduction. Am J Pathol. 2003;163:621-632. (Pubitemid 36909423)
10. Schievenbusch S, Strack I, Scheffler M, Wennhold K, Maurer J, Nischt R, et al. Profiling of anti-fibrotic signaling by hepatocyte growth factor in renal fibroblasts. Biochem Biophys Res Commun. 2009;385:55-61.
11. Mizuno S, Matsumoto K, Nakamura T. Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy. Kidney Int. 2001;59:1304-1314. (Pubitemid 32281218)
12. Yang J, Dai C, Liu Y. Systemic administration of naked plasmid encoding hepatocyte growth factor ameliorates chronic renal fibrosis in mice. Gene Ther. 2001;8:1470-1479. (Pubitemid 32994658)
13. Zhu JS, Halpern GM, Jones K. The scientific rediscovery of an ancient Chinese herbal medicine: Cordyceps sinensis: part I. J Altern Complement Med. 1998;4:289-303. (Pubitemid 128540688)
14. Shahed AR, Kim SI, Shoskes DA. Down regulation of apoptotic and inflammatory genes by cordyceps sinensis extract in rat kidney following ischemia/reperfusion. Transplant Proc. 2001;33: 2986-2987. (Pubitemid 32785621)
15. Wang Y, Yin H, Lv X, Wang Y, Gao H, Wang M. Protection of chronic renal failure by a polysaccharide from Cordyceps sinensis. Fitoterapia. 2010;81:397-402.
16. Guo P, Kai Q, Gao J, Lian ZQ, Wu CM, Wu CA, et al. Cordycepin prevents hyperlipidemia in hamsters fed a high-fat diet via activation of AMP-activated protein kinase. J Pharmacol Sci. 2010;113:395-403.
17. Yang J, Chen S, Huang L, Michalopoulos GK, Liu Y. Sustained expression of naked plasmid DNA encoding hepatocyte growth factor in mice promotes liver and overall body growth. Hepatology. 2001;33:848-859. (Pubitemid 32246634)
18. Liu Y, Rajur K, Tolbert E, Dworkin LD. Endogenous hepatocyte growth factor ameliorates chronic renal injury by activating matrix degradation pathways. Kidney Int. 2000;58:2028-2043.
19. Liu Y. Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action. Am J Physiol Renal Physiol. 2004;287:F7-F16. (Pubitemid 38780577)
20. Badid C, Vincent M, Fouque D, Laville M, Desmouliere A. Myofibroblast: a prognostic marker and target cell in progressive renal disease. Renal Fail. 2001;23:543-549. (Pubitemid 32692288)
21. Massague J. How cells read TGF-beta signals. Nat Rev Mol Cell Biol. 2000;1:169-178.
22. Mehra A, Wrana JL. TGF-beta and the Smad signal transduction pathway. Biochem Cell Biol. 2002;80:605-622. (Pubitemid 36124821)
23. Wotton D, Massague J. Smad transcriptional corepressors in TGF beta family signaling. Curr Top Microbiol Immunol. 2001;254: 145-164.
24. Schnaper HW, Hayashida T, Poncelet AC. It's a Smad world: regulation of TGF-beta signaling in the kidney. J Am Soc Nephrol. 2002;13:1126-1128. (Pubitemid 34274113)
25. Zhu JS, Halpern GM, Jones K. The scientific rediscovery of an ancient Chinese herbal medicine: Cordyceps sinensis. J Altern Complem Med. 1998;4:289-303. (Pubitemid 128540688)
26. Won KJ, Lee SC, Lee CK, Lee HM, Lee SH, Fang Z, et al. Cordycepin attenuates neointimal formation by inhibiting reactive oxygen species - mediated responses in vascular smooth muscle cells in rats. J Pharmacol Sci. 2009;109:403-412.
27. Tsai YJ, Lin LC, Tsai TH. Pharmacokinetics of adenosine and cordycepin, a bioactive constituent of Cordyceps sinensis in rat. J Agric Food Chem. 2010;58:4638-4643.
28. Dworkin LD, Gong R, Tolbert E, Centracchio J, Yano N, Zanabli AR, et al. Hepatocyte growth factor ameliorates progression of interstitial fibrosis in rats with established renal injury. Kidney Int. 2004;65:409-419. (Pubitemid 38130635)
29. Liu Y. Hepatocyte growth factor and the kidney. Curr Opin Nephrol Hypertens. 2002;11:23-30. (Pubitemid 34053334)
30. Ponzetto C, Bardelli A, Zhen Z, Maina F, dalla Zonca P, Giordano S, et al. A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family. Cell. 1994;77:261-271. (Pubitemid 24138623)